Mechanisms of type 2 diabetes resolution after Roux-en-Y gastric bypass

Area of Science:

• Endocrinology
• Metabolic Surgery
• Gastroenterology

Background:

• Bariatric surgery is the most effective treatment for obesity and type 2 diabetes mellitus (T2 DM).
• Roux-en-Y gastric bypass (RYGB) is a common bariatric procedure.
• Longitudinal assessment of hormonal and tissue responses after RYGB is crucial for understanding its metabolic effects.

Purpose of the Study:

• To longitudinally assess hormonal and tissue responses after RYGB.
• To investigate the impact of RYGB on glucose metabolism, insulin sensitivity, and GLP-1 levels.
• To correlate changes in body composition with metabolic improvements post-surgery.

Main Methods:

• Eight patients (5 with T2 DM) underwent RYGB.
• Standardized test meals (STM), hyperinsulinemic-euglycemic clamps (E-clamp), and hyperglycemic clamps (H-clamp) were performed pre- and post-surgery at various time points.
• Glucagon-like peptide-1 (GLP-1) was infused during H-clamps, and body composition was assessed using DXA.

Main Results:

• STM glucose and insulin responses normalized by 3-6 months post-RYGB.
• GLP-1 levels significantly increased early on, normalizing by 12-15 months.
• Insulin sensitivity (M of E-clamp) improved progressively from 3 months, associated with fat mass loss, while β-cell sensitivity improved at 12 months.

Conclusions:

• Early GLP-1 hypersecretion post-RYGB contributes to hyperinsulinemia and glucose normalization.
• Enhanced peripheral insulin sensitivity and fat mass reduction occur within 3-12 months.
• A feedback loop exists between peripheral tissue sensitivity, β-cell function, and L-cell (GLP-1) responses after RYGB.